Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 7028 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 7796 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 7938 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 9592 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 10000 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 10558 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 10708 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 11559 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 13678 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 17635 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 18262 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 18427 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 18575 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ORNITHINE (M+H)+ | 35745 | Peak area normalized | female | diabetic | no neuropathy |